Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia
Authors:
- Katharina A. SchindlbeckKSKatharina A. Schindlbeck
- Chris C. TangCTChris C. Tang
- Martin NiethammerMNMartin Niethammer
- Yoon Young ChoiYCYoon Young Choi
- Daniel MarkowitzDMDaniel Markowitz
- Amir NazemANAmir Nazem
- Dominic NardiDNDominic Nardi
- Nicholas CarrasNCNicholas Carras
- Andrew FeiginAFAndrew Feigin
- Yilong MaYMYilong Ma
- Shichun PengSPShichun Peng
Open Access
- 19 October 2017
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 2 (20)
Abstract
In a rodent model of Parkinson’s disease (PD), levodopa-induced involuntary movements have been linked to striatal angiogenesis — a process that is difficult to document in living human subjects. Angiogenesis can be accompanied by localized increases in cerebral blood flow (CBF) responses to hypercapnia. We therefore explored the possibility that, in the absence of levodopa, local hypercapnic CBF responses are abnormally increased in PD patients with levodopa-induced dyskinesias (LID) but not in their nondyskinetic (NLID) counterparts. We used H 2 15 O PET to scan 24 unmedicated PD subjects (12 LID and 12 NLID) and 12 matched healthy subjects in the rest state under normocapnic and hypercapnic conditions. Hypercapnic CBF responses were compared to corresponding levodopa responses from the same subjects. Group differences in hypercapnic vasoreactivity were significant only in the posterior putamen, with greater CBF responses in LID subjects compared with the other subjects. Hypercapnic and levodopa-mediated CBF responses measured in this region exhibited distinct associations with disease severity: the former correlated with off-state motor disability ratings but not symptom duration, whereas the latter correlated with symptom duration but not motor disability. These are the first in vivo human findings linking LID to microvascular changes in the basal ganglia.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (Morris K. Udall Center of Excellence for Parkinson’s Disease Research at The Feinstein Institute for Medical Research (P50 NS071675 to D.E.))
This publication has 32 references indexed in Scilit:
- Hemodynamic Response Imaging: A Potential Tool for the Assessment of Angiogenesis in Brain TumorsPLOS ONE, 2012
- Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesiaBrain, 2011
- Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsyJournal of Neural Transmission, 2011
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's DiseaseThe Journal of Neuroscience, 2010
- On the assessment of cerebrovascular reactivity using hypercapnia BOLD MRINMR in Biomedicine, 2009
- Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's DiseaseThe Journal of Neuroscience, 2008
- Distribution of the dopamine innervation in the macaque and human thalamusNeuroImage, 2007
- Massive Inborn Angiogenesis in the Brain Scarcely Raises Cerebral Blood FlowJournal of Cerebral Blood Flow & Metabolism, 2004
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992